McKesson Corporation is expected to release its latest quarterly earnings report on Wednesday, May 6th, with a consensus estimated EPS of $11.56.
McKesson Corporation, trading at $837.66, experienced a price increase of $9.34 (1.13%) from the previous close of $828.32. The trading volume is $119,566, representing a 14.79% increase from the average.
The company's latest quarterly earnings report, released on Tuesday, February 3rd, showed a consensus EPS of $9.31. The earnings date revealed a net income of $1.19 billion.
McKesson Corporation offers a forward dividend yield of 0.392%, with a dividend per share of 82 cents (MRQ). Year-over-year, the dividend per share increased by 15.0376 cents to $3.17 per share.
The company reported a free cash flow of $1.12 billion, with a net change in cash of -$1 billion. Operating cash flow stood at $1.23 billion, while debt repayment amounted to $1.20 billion.
McKesson Corporation's revenue reached $106.16 billion, generating a gross profit of $3.69 billion. The net income for the period was $1.19 billion, resulting in an EPS of $9.63.
Key ratios for McKesson Corporation include a gross profit margin of 3.47%, a net profit margin of 1.12%, and a return on assets of 1.41. The price-earnings ratio is 21.3, while the price to free cash flows ratio stands at 89.91.
The company's total assets amount to $84.19 billion, with total liabilities at $84.29 billion. Cash and cash equivalents are reported at $2.96 billion, and total debt stands at $8.62 billion.
This real-time financial report provides insights into McKesson Corporation's current performance and financial health.
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.